The study found that nerandomilast effectively slowed lung function decline in patients, with discontinuation rates similar to placebo
The drug is designed to improve functional capacity and reduce symptoms by inhibiting cardiac myosin motor activity
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
A key highlight will be Brenntag’s qualified amino acids portfolio
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
Tofacitinib extended-release tablets are a Janus kinase inhibitor indicated for Rheumatoid Arthritis
Subscribe To Our Newsletter & Stay Updated
